Carisma Therapeutics Inc.
Company Information
Industry Pharmaceutical Preparations
SIC Code 2834
Entity Type operating
SEC Category Non-accelerated filerSmaller reporting company
State of Incorporation DE
Business Address 3675 MARKET STREET, PHILADELPHIA, PA, 19104
Mailing Address 3675 MARKET STREET, PHILADELPHIA, PA, 19104
Phone 2674916422
Fiscal Year End 1231
EIN 262025616
Financial Overview
FY2024
-$60.48M
Net Income
$77.61M
Cash & Equivalents
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 8-K Current report of material events | December 5, 2025 | View on SEC |
| 10-Q Quarterly financial report | November 12, 2025 | View on SEC |
| 8-K Current report of material events | October 15, 2025 | View on SEC |
| 8-K Current report of material events | October 9, 2025 | View on SEC |
| 4 Insider stock transaction report | October 8, 2025 | View on SEC |
| 4 Insider stock transaction report | October 3, 2025 | View on SEC |
| 8-K Current report of material events | September 18, 2025 | View on SEC |
| SCHEDULE 13D/A Beneficial ownership amendment | September 2, 2025 | View on SEC |
| 8-K Current report of material events | August 29, 2025 | View on SEC |
| SCHEDULE 13D/A Beneficial ownership amendment | August 29, 2025 | View on SEC |
Material Events
8-K Financial Distress December 5, 2025
High Impact
- Carisma Therapeutics Inc. is voluntarily delisting its stock from the Nasdaq exchange.
- The company plans to stop filing regular financial reports with the SEC.
Related Companies
Companies in the same industry (SIC: 2834)
Werewolf Therapeutics, Inc.
HOWL Pharmaceutical Preparations
Zenas BioPharma, Inc.
ZBIO Pharmaceutical Preparations
Centessa Pharmaceuticals plc
CNTA Pharmaceutical Preparations
Karyopharm Therapeutics Inc.
KPTI Pharmaceutical Preparations
VERTEX PHARMACEUTICALS INC / MA
VRTX Pharmaceutical Preparations
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.